Income Statement Vasundhara Rasayans Limited

Stocks

VRL6

INE406F01010

Pharmaceuticals

Market Closed - Bombay S.E. 08:02:23 12/08/26 pm AEST			5-day change	1st Jan Change
173.60 ^INR	-4.51%		-2.55%	+2.06%

01/08	Vasundhara Rasayans Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026	CI
28/05	Vasundhara Rasayans Limited Enters Memorandum of Understanding Cum Loan-Lease Agreement with Pandj Cretechem Private Limited for Manufacturing of Active Pharmaceutical Ingredients	CI

67.IVn0wToASJnbd21Zq7sd0NdizQEI3dfwaH5ggiPU07k.Yy669WowGauWLjtvk_pJ6bgHvUxctIekXR0CymWZp9FuFLiJAzE43K0HWQ

Published financial data: VASUNDHARA RASAYANS LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022	2023	2024	2025	2026
Revenues	268M	379M	370M	340M	357M
Other Revenues, Total	-	-1K	-	-	-
Total Revenues	268M	379M	370M	340M	357M
Cost of Goods Sold, Total	140M	185M	164M	159M	153M
Gross Profit	127M	194M	207M	181M	204M
Selling General & Admin Expenses, Total	30.19M	35.65M	41.85M	43.53M	43.64M
Depreciation & Amortization - (IS)	1.15M	1.31M	2.64M	3.57M	4.3M
Other Operating Expenses	74.81M	103M	98.55M	95.74M	102M
Other Operating Expenses, Total	106M	140M	143M	143M	150M
Operating Income	21.07M	54.11M	63.47M	38.42M	53.84M
Interest Expense, Total	-444K	-2M	-1.74M	-2.69M	-4.03M
Interest And Investment Income	5.68M	9.34M	15.09M	20.59M	25.79M
Net Interest Expenses	5.24M	7.34M	13.36M	17.89M	21.76M
Currency Exchange Gains (Loss)	491K	2.68M	528K	1.23M	33K
Other Non Operating Income (Expenses)	-	1.03M	1K	4K	2.23M
EBT, Excl. Unusual Items	26.8M	65.17M	77.35M	57.55M	77.86M
Gain (Loss) On Sale Of Investments	3.67M	-	1.6M	103K	773K
Gain (Loss) On Sale Of Assets	-	-	-	-	-
Insurance Settlements	-	9.59M	-	17K	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	30.46M	74.76M	78.95M	57.67M	78.63M
Income Tax Expense	8.74M	18.85M	20.36M	15.21M	20.74M
Earnings From Continuing Operations	21.73M	55.91M	58.59M	42.46M	57.89M
Net Income to Company	21.73M	55.91M	58.59M	42.46M	57.89M
Net Income - (IS)	21.73M	55.91M	58.59M	42.46M	57.89M
Net Income to Common Incl Extra Items	21.73M	55.91M	58.59M	42.46M	57.89M
Net Income to Common Excl. Extra Items	21.73M	55.91M	58.59M	42.46M	57.89M
Per Share Items
Net EPS - Basic	6.84	17.59	18.44	13.27	18.22
Basic EPS - Continuing Operations	6.84	17.59	18.44	13.27	18.22
Basic Weighted Average Shares Outstanding	3.18M	3.18M	3.18M	3.2M	3.18M
Net EPS - Diluted	6.84	17.59	18.44	13.27	18.22
Diluted EPS - Continuing Operations	6.84	17.59	18.44	13.27	18.22
Diluted Weighted Average Shares Outstanding	3.18M	3.18M	3.18M	3.2M	3.18M
Normalized Basic EPS	5.27	12.82	15.21	11.24	15.31
Normalized Diluted EPS	5.27	12.82	15.21	11.24	15.31
Dividend Per Share	1	2	2	2	2
Payout Ratio	21.94	5.68	10.85	14.97	10.98
Supplemental Items
EBITDA	22.22M	55.42M	66.1M	41.99M	58.14M
EBITA	21.07M	54.11M	63.47M	38.42M	53.84M
EBIT	21.07M	54.11M	63.47M	38.42M	53.84M
EBITDAR	29.66M	62.99M	74.97M	52.1M	68.96M
Total Revenues (As Reported)	278M	402M	390M	363M	386M
Effective Tax Rate - (Ratio)	28.68	25.21	25.79	26.37	26.38
Total Current Taxes	8.38M	18.84M	19.45M	14.8M	20.84M
Total Deferred Taxes	48.74K	-25K	479K	13K	-107K
Normalized Net Income	16.75M	40.73M	48.34M	35.97M	48.66M
Non-Cash Pension Expense	399K	-90K	-103K	-29K	2.06M
Supplemental Operating Expense Items
Advertising Expense	91.55K	2.07M	155K	777K	50K
Selling and Marketing Expenses	91.55K	2.07M	155K	777K	50K
Net Rental Expense, Total	7.44M	7.57M	8.86M	10.1M	10.82M
Imputed Operating Lease Interest Expense	-	4.53M	4.13M	7.07M	11.59M
Imputed Operating Lease Depreciation	-	3.04M	4.73M	3.03M	-772K
Maintenance & Repair Expenses, Total	963K	1.34M	1.18M	3.88M	2.32M

Fiscal Period: March	2022	2023	2024	2025	2026
Assets
Cash And Equivalents	108M	77.36M	95.62M	55.41M	25.34M
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	3.22M	-	11.6M	23.52M	25.15M
Total Cash And Short Term Investments	111M	77.36M	107M	78.93M	50.49M
Accounts Receivable, Total	73.35M	80.5M	62.24M	41.54M	74.56M
Other Receivables	1.09M	-	-	5.38M	841K
Notes Receivable	15.14M	128M	153M	245M	296M
Total Receivables	89.58M	208M	215M	292M	371M
Inventory	22.13M	39.99M	17.34M	18.78M	15.24M
Prepaid Expenses	155K	77K	69K	150K	-
Other Current Assets, Total	20.9M	9.69M	8.19M	14.64M	16.76M
Total Current Assets	244M	335M	348M	404M	453M
Gross Property Plant And Equipment	14.01M	14.82M	33.1M	37.32M	40.3M
Accumulated Depreciation	-4.93M	-6.24M	-8.85M	-12.45M	-16.75M
Net Property Plant And Equipment	9.08M	8.58M	24.26M	24.87M	23.55M
Long-term Investments	1.47M	1.28M	518K	542K	563K
Deferred Tax Assets Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	764K	165K	2K	1.3M	1.3M
Total Assets	255M	345M	373M	431M	479M
Liabilities
Accounts Payable, Total	12.46M	13.38M	18.02M	18.19M	28.04M
Accrued Expenses, Total	13.59M	17.34M	9.64M	10.93M	6.76M
Short-term Borrowings	13.11M	40.2M	11.57M	37.2M	14.75M
Current Income Taxes Payable	-	5.75M	5.72M	-	7.69M
Other Current Liabilities	154K	23K	-1K	3.14M	8.75M
Total Current Liabilities	39.31M	76.69M	44.95M	69.47M	65.99M
Long-Term Debt	-	-	7.89M	4.86M	3.34M
Pension & Other Post Retirement Benefits	-	-	-	-	-
Deferred Tax Liability Non Current	353K	328K	806K	819K	712K
Other Non Current Liabilities	-	1K	-	-	-
Total Liabilities	39.66M	77.02M	53.65M	75.15M	70.05M
Common Stock, Total	31.78M	31.78M	31.78M	31.78M	31.78M
Retained Earnings	181M	234M	285M	322M	375M
Comprehensive Income and Other	2.12M	2.12M	2.12M	2.12M	2.12M
Total Common Equity	215M	268M	319M	356M	409M
Total Equity	215M	268M	319M	356M	409M
Total Liabilities And Equity	255M	345M	373M	431M	479M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	3.18M	3.18M	3.18M	3.18M	3.18M
ECS Total Common Shares Outstanding	3.18M	3.18M	3.18M	3.18M	3.18M
Book Value / Share	67.76	84.38	100.49	111.88	128.61
Tangible Book Value	215M	268M	319M	356M	409M
Tangible Book Value Per Share	67.76	84.38	100.49	111.88	128.61
Total Debt	13.11M	40.2M	19.46M	42.06M	18.09M
Net Debt	-97.85M	-37.16M	-87.75M	-36.87M	-32.39M
Debt Equivalent of Unfunded Proj. Benefit Obligation	-1.24M	-1.35M	-337K	-355K	128K
Debt Equivalent Oper. Leases	59.55M	60.55M	70.9M	80.84M	86.54M
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	17.33M	26.2M	10.73M	10.64M	6.33M
Inventories - Work In Process, Total	-	-	-	-	-
Inventories - Finished Goods, Total	4.8M	13.79M	6.61M	8.13M	8.92M
Land - (BS)	-	-	-	-	-
Buildings, Total	-	-	-	-	-
Machinery, Total	14.01M	14.82M	33.1M	37.32M	40.3M
Full Time Employees	38	37	41	33	42

Fiscal Period: March	2022	2023	2024	2025	2026
Net Income	21.73M	55.91M	58.59M	42.46M	57.89M
Depreciation & Amortization - CF	1.15M	1.31M	2.64M	3.57M	4.3M
Depreciation & Amortization, Total	1.15M	1.31M	2.64M	3.57M	4.3M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-3.67M	-376K	-1.6M	-120K	773K
Other Operating Activities, Total	-5.19M	-519K	-12.91M	-28.99M	-9.34M
Change In Accounts Receivable	-11.65M	-7.15M	18.26M	20.7M	-33.02M
Change In Inventories	-8.06M	-17.86M	22.65M	-1.44M	3.53M
Change In Accounts Payable	-524K	2.45M	-6.45M	296K	9.85M
Change in Other Net Operating Assets	85.27M	-98.77M	-20.89M	-94.84M	-49.83M
Cash from Operations	79.04M	-65.01M	60.3M	-58.35M	-15.84M
Capital Expenditure	-3.54M	-811K	-18.31M	-4.19M	-2.98M
Sale of Property, Plant, and Equipment	49.06K	-	-	-	-
Investment in Marketable and Equity Securities, Total	11.69M	4.2M	-10M	-11.8M	-2.4M
Other Investing Activities, Total	5.68M	9.34M	15.09M	20.59M	25.5M
Cash from Investing	13.89M	12.72M	-13.22M	4.6M	20.12M
Short Term Debt Issued, Total	13.11M	27.09M	-	25.63M	-
Long-Term Debt Issued, Total	-	-	7.89M	-	-
Total Debt Issued	13.11M	27.09M	7.89M	25.63M	-
Short Term Debt Repaid, Total	-	-	-28.62M	-	-22.45M
Long-Term Debt Repaid, Total	-	-	-	-3.03M	-1.52M
Total Debt Repaid	-	-	-28.62M	-3.03M	-23.97M
Common Dividends Paid	-4.77M	-3.18M	-6.36M	-6.36M	-6.36M
Common & Preferred Stock Dividends Paid	-4.77M	-3.18M	-6.36M	-6.36M	-6.36M
Other Financing Activities, Total	-444K	-2M	-1.74M	-2.69M	-4.03M
Cash from Financing	7.89M	21.92M	-28.83M	13.55M	-34.35M
Miscellaneous Cash Flow Adjustments	0	-	-	-	-
Net Change in Cash	101M	-30.37M	18.26M	-40.2M	-30.07M
Supplemental Items
Cash Interest Paid	444K	2M	1.74M	2.69M	4.03M
Cash Income Tax Paid (Refund)	8.69M	12.02M	19.91M	26.3M	8.32M
Levered Free Cash Flow	-6.65M	-81.69M	36.57M	-63.45M	-26.39M
Unlevered Free Cash Flow	-6.37M	-80.44M	37.65M	-61.76M	-23.87M
Change In Net Working Capital	17.15M	115M	-13.66M	85.16M	58.84M
Net Debt Issued / Repaid	13.11M	27.09M	-20.73M	22.6M	-23.97M

Fiscal Period: March	2022	2023	2024	2025	2026
Profitability
Return on Assets	5.43	11.27	11.05	5.98	7.4
Return on Total Capital	6.16	12.6	12.26	6.52	8.16
Return On Equity %	10.49	23.12	19.94	12.58	15.15
Return on Common Equity	10.49	23.12	19.94	12.58	15.15
Margin Analysis
Gross Profit Margin %	47.56	51.23	55.78	53.33	57.07
SG&A Margin	11.29	9.4	11.31	12.81	12.21
EBITDA Margin %	8.3	14.61	17.86	12.35	16.27
EBITA Margin %	7.88	14.26	17.14	11.3	15.07
EBIT Margin %	7.88	14.26	17.14	11.3	15.07
Income From Continuing Operations Margin %	8.12	14.74	15.83	12.49	16.21
Net Income Margin %	8.12	14.74	15.83	12.49	16.21
Net Avail. For Common Margin %	8.12	14.74	15.83	12.49	16.21
Normalized Net Income Margin	6.26	10.74	13.06	10.58	13.62
Levered Free Cash Flow Margin	-2.49	-21.53	9.88	-18.67	-7.39
Unlevered Free Cash Flow Margin	-2.38	-21.2	10.17	-18.17	-6.68
Asset Turnover
Asset Turnover	1.1	1.26	1.03	0.85	0.79
Fixed Assets Turnover	33.8	42.96	22.55	13.84	14.76
Receivables Turnover (Average Receivables)	3.96	4.93	5.19	6.55	6.15
Inventory Turnover (Average Inventory)	7.75	5.96	5.71	8.78	9.01
Short Term Liquidity
Current Ratio	6.2	4.37	7.75	5.82	6.87
Quick Ratio	4.72	2.06	3.77	1.81	1.91
Operating Cash Flow to Current Liabilities	2.01	-0.85	1.34	-0.84	-0.24
Days Sales Outstanding (Average Receivables)	92.14	74.01	70.57	55.72	59.31
Days Outstanding Inventory (Average Inventory)	47.08	61.26	64.1	41.55	40.49
Average Days Payable Outstanding	32.22	23.24	55.12	41.15	56.33
Cash Conversion Cycle (Average Days)	107	112.03	79.55	56.13	43.47
Long Term Solvency
Total Debt/Equity	6.09	14.99	6.09	11.83	4.43
Total Debt / Total Capital	5.74	13.03	5.74	10.58	4.24
LT Debt/Equity	-	-	2.47	1.37	0.82
Long-Term Debt / Total Capital	-	-	2.33	1.22	0.78
Total Liabilities / Total Assets	15.55	22.31	14.38	17.45	14.63
EBIT / Interest Expense	47.46	27.12	36.52	14.27	13.37
EBITDA / Interest Expense	50.05	27.78	38.04	15.6	14.43
(EBITDA - Capex) / Interest Expense	42.08	27.37	27.5	14.04	13.69
Total Debt / EBITDA	0.59	0.73	0.29	1	0.31
Net Debt / EBITDA	-4.4	-0.67	-1.33	-0.88	-0.56
Total Debt / (EBITDA - Capex)	0.7	0.74	0.41	1.11	0.33
Net Debt / (EBITDA - Capex)	-5.24	-0.68	-1.84	-0.98	-0.59
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	17.95	41.83	-2.43	-8.18	5.1
Gross Profit, 1 Yr. Growth %	7.15	52.86	6.51	-12.22	12.48
EBITDA, 1 Yr. Growth %	-29.61	149.48	19.27	-36.48	38.45
EBITA, 1 Yr. Growth %	-32.16	156.87	17.28	-39.46	40.12
EBIT, 1 Yr. Growth %	-32.16	156.87	17.28	-39.46	40.12
Earnings From Cont. Operations, 1 Yr. Growth %	-25.99	157.34	4.8	-27.53	36.33
Net Income, 1 Yr. Growth %	-25.99	157.34	4.8	-27.53	36.33
Normalized Net Income, 1 Yr. Growth %	-32.37	143.2	18.69	-25.6	35.29
Diluted EPS Before Extra, 1 Yr. Growth %	-25.99	157.32	4.82	-27.53	36.35
Accounts Receivable, 1 Yr. Growth %	18.89	9.75	-22.69	-33.26	79.49
Inventory, 1 Yr. Growth %	57.32	80.82	-56.64	8.28	-18.82
Net Property, Plant and Equip., 1 Yr. Growth %	34.67	-5.49	182.59	2.55	-5.33
Total Assets, 1 Yr. Growth %	10.85	35.36	8.06	15.47	11.16
Tangible Book Value, 1 Yr. Growth %	8.38	24.52	19.09	11.33	14.95
Common Equity, 1 Yr. Growth %	8.38	24.52	19.09	11.33	14.95
Cash From Operations, 1 Yr. Growth %	3.55K	-182.25	-192.75	-196.76	-72.85
Capital Expenditures, 1 Yr. Growth %	-16.75	-77.07	2.16K	-77.11	-29.01
Levered Free Cash Flow, 1 Yr. Growth %	-118.98	1.13K	-144.76	-273.51	-58.41
Unlevered Free Cash Flow, 1 Yr. Growth %	-117.96	1.16K	-146.81	-264.04	-61.35
Dividend Per Share, 1 Yr. Growth %	-33.33	100	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	12.11	29.34	17.64	-5.35	-1.77
Gross Profit, 2 Yr. CAGR %	4.12	27.95	27.44	-3.31	-0.64
EBITDA, 2 Yr. CAGR %	-12.55	32.52	72.5	-12.96	-6.22
EBITA, 2 Yr. CAGR %	-14.46	32.01	73.57	-15.74	-7.9
EBIT, 2 Yr. CAGR %	-14.46	32.01	73.57	-15.74	-7.9
Earnings From Cont. Operations, 2 Yr. CAGR %	-14.73	38	64.22	-12.85	-0.6
Net Income, 2 Yr. CAGR %	-14.73	38	64.22	-12.85	-0.6
Normalized Net Income, 2 Yr. CAGR %	-16.61	28.25	69.9	-6.02	0.33
Diluted EPS Before Extra, 2 Yr. CAGR %	-14.73	38	64.23	-13.14	-0.26
Accounts Receivable, 2 Yr. CAGR %	8.55	14.23	-7.89	-28.17	9.45
Inventory, 2 Yr. CAGR %	21.62	68.62	-11.45	-31.48	-6.24
Net Property, Plant and Equip., 2 Yr. CAGR %	73.95	12.81	63.42	70.24	-1.47
Total Assets, 2 Yr. CAGR %	1.62	22.49	20.94	11.7	13.29
Tangible Book Value, 2 Yr. CAGR %	11.22	16.17	21.78	15.15	13.13
Common Equity, 2 Yr. CAGR %	11.22	16.17	21.78	15.15	13.13
Cash From Operations, 2 Yr. CAGR %	371.65	447.82	-12.66	-5.26	-48.75
Capital Expenditures, 2 Yr. CAGR %	66.6	-56.31	127.52	127.33	-59.69
Levered Free Cash Flow, 2 Yr. CAGR %	-37.08	52.71	134.51	-11.87	-15.05
Unlevered Free Cash Flow, 2 Yr. CAGR %	-38.76	50.61	143.09	-12.37	-20.38
Dividend Per Share, 2 Yr. CAGR %	-18.35	15.47	41.42	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	10.61	21.25	17.74	8.31	-1.99
Gross Profit, 3 Yr. CAGR %	7.08	18.32	20.26	12.54	1.69
EBITDA, 3 Yr. CAGR %	23.96	24.02	27.95	23.64	1.61
EBITA, 3 Yr. CAGR %	23.42	23.41	26.9	22.18	-0.17
EBIT, 3 Yr. CAGR %	23.42	23.41	26.9	22.18	-0.17
Earnings From Cont. Operations, 3 Yr. CAGR %	14.36	23.22	25.9	25.03	1.17
Net Income, 3 Yr. CAGR %	14.36	23.22	25.9	25.03	1.17
Normalized Net Income, 3 Yr. CAGR %	8.91	19.15	24.98	29.02	6.11
Diluted EPS Before Extra, 3 Yr. CAGR %	14.37	23.22	25.91	24.74	1.17
Accounts Receivable, 3 Yr. CAGR %	12.79	8.95	0.29	-17.27	-2.53
Inventory, 3 Yr. CAGR %	12.64	38.79	7.23	-5.31	-27.49
Net Property, Plant and Equip., 3 Yr. CAGR %	65.87	41.94	53.21	39.91	39.99
Total Assets, 3 Yr. CAGR %	6.99	11.81	17.48	19.09	11.52
Tangible Book Value, 3 Yr. CAGR %	13.3	15.49	17.14	18.19	15.08
Common Equity, 3 Yr. CAGR %	13.3	15.49	17.14	18.19	15.08
Cash From Operations, 3 Yr. CAGR %	164.08	163.5	203.06	-9.63	-37.54
Capital Expenditures, 3 Yr. CAGR %	35.8	-13.98	62.74	5.82	54.23
Levered Free Cash Flow, 3 Yr. CAGR %	-41.68	69.43	1.44	112.1	-31.38
Unlevered Free Cash Flow, 3 Yr. CAGR %	-42.39	67.92	2.02	113.22	-33.3
Dividend Per Share, 3 Yr. CAGR %	0	10.06	10.06	25.99	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.61	17.98	13.37	9.81	9.51
Gross Profit, 5 Yr. CAGR %	8.97	18.44	14.79	9.09	11.42
EBITDA, 5 Yr. CAGR %	3.42	24.29	41.47	7.65	13
EBITA, 5 Yr. CAGR %	9.8	28.36	41.46	5.94	11.63
EBIT, 5 Yr. CAGR %	9.8	28.36	41.46	5.94	11.63
Earnings From Cont. Operations, 5 Yr. CAGR %	36.31	-3.03	32.17	7.28	14.55
Net Income, 5 Yr. CAGR %	36.31	-3.03	32.17	7.28	14.55
Normalized Net Income, 5 Yr. CAGR %	18.88	31	30.11	8.36	14.47
Diluted EPS Before Extra, 5 Yr. CAGR %	36.36	-3.02	32.18	7.13	14.55
Accounts Receivable, 5 Yr. CAGR %	14.2	6.14	4.02	-7.77	3.86
Inventory, 5 Yr. CAGR %	11.56	25.94	2.29	4.65	1.62
Net Property, Plant and Equip., 5 Yr. CAGR %	-33.11	52.6	64.89	52.64	28.41
Total Assets, 5 Yr. CAGR %	13.65	11.12	12.36	11.77	15.79
Tangible Book Value, 5 Yr. CAGR %	24.44	14.32	16.62	15.35	15.52
Common Equity, 5 Yr. CAGR %	24.44	14.32	16.62	15.35	15.52
Cash From Operations, 5 Yr. CAGR %	26.76	-9.49	69.64	75.02	48.87
Capital Expenditures, 5 Yr. CAGR %	38.98	-	66.94	26.89	-6.88
Levered Free Cash Flow, 5 Yr. CAGR %	-23.32	29.08	1.76	30.45	-5.51
Unlevered Free Cash Flow, 5 Yr. CAGR %	-25.28	29.75	2.48	29.45	-7.61
Dividend Per Share, 5 Yr. CAGR %	0	14.87	14.87	5.92	5.92